Mariner, LLC Seagen Inc. Transaction History

Mariner, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$191.51 - $216.16 $133,482 - $150,663	697 Added 8.58%	8,822 $1.87 Million
Q2 2023 Aug 11, 2023	SELL	$187.64 - $206.25 $417,498 - $458,906	-2,225 Reduced 21.5%	8,125 $1.56 Million
Q1 2023 May 12, 2023	BUY	$127.59 - $203.08 $86,123 - $137,079	675 Added 6.98%	10,350 $2.1 Million
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $169,834 - $201,378	-1,447 Reduced 13.01%	9,675 $1.24 Million
Q3 2022 Nov 10, 2022	BUY	$135.27 - $180.11 $114,979 - $153,093	850 Added 8.27%	11,122 $1.52 Million

Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $1.12 Million - $1.84 Million	10,272 New	10,272 $1.82 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.